Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Hui Lai Zhang"'
Autor:
Fei Luo, Qiu-Zi Zhong, Xin Liu, Xiao-Rong Hou, Li-Ting Qian, Xue-Ying Qiao, Hua Wang, Yuan Zhu, Jian-Zhong Cao, Jun-Xin Wu, Tao Wu, Su-Yu Zhu, Mei Shi, Hui-Lai Zhang, Xi-Mei Zhang, Hang Su, Yu-Qin Song, Jun Zhu, Yu-Jing Zhang, Hui-Qiang Huang, Ying Wang, Xia He, Li-Ling Zhang, Bao-Lin Qu, Yong Yang, Chen Hu, Min Deng, Shu-Lian Wang, Shu-Nan Qi, Ye-Xiong Li
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: Extranodal natural killer/T-cell lymphoma (ENKTCL) has a unique treatment principle. However, the optimal combination of drugs along with radiotherapy (RT) is unknown. Design: Retrospective cohort study. Objectives: We screened multiple d
Externí odkaz:
https://doaj.org/article/9e7defbd604e4ca0b4d2bad799567107
Autor:
Yu-Qin Song, Hui-Lai Zhang, Hui-Qiang Huang, Qing-Yuan Zhang, Hong-Mei Jing, Chao Wang, Chun Wu, Dong-Hang Li, Yu Dai, Kathryn Humphrey, Jun Zhu
Publikováno v:
Haematologica, Vol 109, Iss 4 (2023)
Externí odkaz:
https://doaj.org/article/93e78c719a5a4321882c78d1c7c3a079
Autor:
Xuan Zheng, Bao‐Lin Qu, Xin Liu, Qiu‐Zi Zhong, Li‐Ting Qian, Yong Yang, Xiao‐Rong Hou, Xue‐Ying Qiao, Hua Wang, Yuan Zhu, Jian‐Zhong Cao, Jun‐Xin Wu, Tao Wu, Su‐Yu Zhu, Mei Shi, Hui‐Lai Zhang, Xi‐Mei Zhang, Hang Su, Yu‐Qin Song, Jun Zhu, Yu‐Jing Zhang, Hui‐Qiang Huang, Ying Wang, Fan Chen, Lin Yin, Xia He, Li‐Ling Zhang, Ye‐Xiong Li, Shu‐Nan Qi
Publikováno v:
eJHaem, Vol 4, Iss 1, Pp 78-89 (2023)
Abstract This study aimed to investigate the characteristics and prognosis of distant metastasis (DM) after primary treatment for early‐stage extranodal nasal‐type natural killer (NK)/T‐cell lymphoma (ENKTCL). A total of 1619 patients from the
Externí odkaz:
https://doaj.org/article/75d616809d12419c8c8387747161de72
Autor:
Wen-Cai Tao, Xue-Yan Zhang, Yue Zhang, Xiao-Yue Deng, Hui-Lai Zhang, Zhi-Hui Zhang, Qing Li, Chun-Xian Jiang
Publikováno v:
Insects, Vol 15, Iss 1, p 26 (2024)
In this paper, the effects of maize and its three intercropping plants, sweet potato, soybean and peanut, on the growth and development of FAW, feeding preference of larvae, olfactory response and oviposition preference of adults were studied in the
Externí odkaz:
https://doaj.org/article/b9ca5e828bdc455f85479d4714082102
Autor:
Jia‐Xin Liu, Xin Liu, Yong Yang, Wei‐Ping Liu, Ying Wang, Xia He, Li‐Ling Zhang, Bao‐Lin Qu, Li‐Ting Qian, Xiao‐Rong Hou, Xue‐Ying Qiao, Hua Wang, Gao‐Feng Li, Yuan Zhu, Jian‐Zhong Cao, Jun‐Xin Wu, Tao Wu, Su‐Yu Zhu, Mei Shi, Hui‐Lai Zhang, Hang Su, Yu‐Jing Zhang, Jun Zhu, Shu‐Nan Qi, Ye‐Xiong Li, Yu‐Qin Song
Publikováno v:
Cancer Reports, Vol 6, Iss 5, Pp n/a-n/a (2023)
Abstract Background The gastrointestinal (GI) tract is the second most frequent extranasal involvement site for ENKTL. This study aimed to explore the clinicopathological features, treatment models, survival outcomes, and prognosis of gastrointestina
Externí odkaz:
https://doaj.org/article/ff3ac48efb1f455c88da07260ec2435a
Autor:
Xin Liu, Li-Ling Zhang, Bao-Lin Qu, Qiu-Zi Zhong, Li-Ting Qian, Yong Yang, Xiao-Rong Hou, Xue-Ying Qiao, Hua Wang, Yuan Zhu, Jian-Zhong Cao, Jun-Xin Wu, Tao Wu, Su-Yu Zhu, Mei Shi, Hui-Lai Zhang, Xi-Mei Zhang, Hang Su, Yu-Qin Song, Jun Zhu, Yu-Jing Zhang, Hui-Qiang Huang, Ying Wang, Fan Chen, Lin Yin, Xia He, Shang Cai, Ye-Xiong Li, Shu-Nan Qi
Publikováno v:
Haematologica, Vol 108, Iss 9 (2023)
Survival from extranodal nasal-type NK/T-cell lymphoma (ENKTCL) has substantially improved over the last decade. However, there is little consensus as to whether a population of patients with ENKTCL can be considered “cured” of the disease. We ai
Externí odkaz:
https://doaj.org/article/4a6d55ac31344c1f97642ddee1789d16
Autor:
Mei-ting Chen, Fei Pan, Yung-chang Chen, Wei Zhang, Hui-juan Lv, Zhao Wang, Huang-ming Hong, Xiao-jie Fang, Ya-wen Wang, Tao Pan, Li-qun Zou, Hong-qiang Guo, Ke Xie, Li-min Chen, Xiao-qian Li, Yu-yi Yao, Ze-geng Chen, Hua-wei Weng, Xu-dong Li, Yuan-yuan Shen, Hui Zhou, Hong-wei Xue, Hui-lai Zhang, He Huang, Tong-yu Lin
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Adult sporadic Burkitt lymphoma (BL) is a rare but highly aggressive subtype of lymphoma which lacks its own unique prognostic model. Systemic inflammatory biomarkers have been confirmed as prognostic markers in several types of m
Externí odkaz:
https://doaj.org/article/085eb186ea544bb4a14ce0b595e4d080
Autor:
Xuan Zheng, Bao‐Lin Qu, Xin Liu, Qiu‐Zi Zhong, Li‐Ting Qian, Yong Yang, Xiao‐Rong Hou, Xue‐Ying Qiao, Hua Wang, Yuan Zhu, Jian‐Zhong Cao, Jun‐Xin Wu, Tao Wu, Su‐Yu Zhu, Mei Shi, Hui‐Lai Zhang, Xi‐Mei Zhang, Hang Su, Yu‐Qin Song, Jun Zhu, Yu‐Jing Zhang, Hui‐Qiang Huang, Ying Wang, Fan Chen, Lin Yin, Xia He, Li‐Ling Zhang, Ye‐Xiong Li, Shu‐Nan Qi
Publikováno v:
eJHaem. 4:78-89
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61330354a55376ed50ec7970622b795c
https://doi.org/10.1002/jha2.613
https://doi.org/10.1002/jha2.613
Autor:
Li-Juan Deng, Ke-Shu Zhou, Li-Hong Liu, Ming-Zhi Zhang, Zhi-Ming Li, Chun-Yan Ji, Wei Xu, Ting Liu, Bing Xu, Xin Wang, Su-Jun Gao, Hui-Lai Zhang, Yu Hu, Yan Li, Ying Cheng, Hai-Yan Yang, Jun-Ning Cao, Zunmin Zhu, Jian-Da Hu, Wei Zhang, Hong-Mei Jing, Kai-Yang Ding, Xiang-Yang Zhang, Renbin Zhao, Bin Zhang, Ya-Min Tian, Yong-Ping Song, Yu-Qin Song, Jun Zhu
Publikováno v:
Blood Advances.
Relapsed or refractory (r/r) mantle cell lymphoma (MCL) is an aggressive B-cell malignancy with poor prognosis. Bruton's tyrosine kinase (BTK) is a mediator of B-cell receptor signaling and is associated with the development of B-cell lymphomas. Pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81459edf4e8140dcbb282d8e541815a4
https://doi.org/10.1182/bloodadvances.2022009168
https://doi.org/10.1182/bloodadvances.2022009168
Autor:
Zhi Ming Li, Junning Cao, Huaqing Wang, J Feng, Jie Jin, Huiqiang Huang, Xiaoxiao Wang, Qingqing Cai, Hui-Lai Zhang, Yan Gao, Wenqi Jiang
Publikováno v:
Annals of Hematology. 100:2961-2968
This study aimed to identify the maximum-tolerated dose (MTD) of cyclophosphamide when combined with bortezomib and fludarabine (B-FC) in a phase 1b trial, and to assess the efficacy and safety of this combination in a phase 2 trial in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74cae20edcb43186cedcef6dcd7844d8
https://doi.org/10.1007/s00277-021-04619-4
https://doi.org/10.1007/s00277-021-04619-4